These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9013802)

  • 1. Pharmacological profiles of a new antiulcer agent, SWR-215.
    Kataoka H; Isoi T; Kiso T; Tanaka C; Shinkawa R; Kakita T; Shogaki T; Furukawa M; Ohtsubo Y
    Biol Pharm Bull; 1997 Jan; 20(1):28-35. PubMed ID: 9013802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of Cuban analog (SWR-104SA), a new histamine H2 receptor antagonist, on gastric acid secretion and experimental ulcer formation].
    Shinkawa R; Kiso T; Kataoka H; Isoi T; Kakita T; Shogaki T; Ohtsubo Y
    Yakugaku Zasshi; 1996 Oct; 116(10):783-91. PubMed ID: 8950870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine.
    Okabe S; Takagi K; Igata H; Kato S; Shimosako K; Yamaji Y; Seiki M
    Jpn J Pharmacol; 1992 Jul; 59(3):275-89. PubMed ID: 1359178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of IGN-2098, a new histamine H2-receptor antagonist, on gastric secretion and gastric and duodenal lesions induced in rats. Comparison with roxatidine].
    Okabe S; Narita M; Nakaji S; Takinami Y; Kawano O; Misaki N
    Nihon Yakurigaku Zasshi; 1992 Mar; 99(3):167-80. PubMed ID: 1354631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical and biologic characteristics of roxatidine acetate.
    Bickel M; Herling AW; Schoelkens B; Scholtholt J
    Scand J Gastroenterol Suppl; 1988; 146():78-88. PubMed ID: 2906471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats.
    Shibata M; Yamaura T; Sekine A; Nishikawa M; Chida Y; Ohnishi H
    Jpn J Pharmacol; 1990 Nov; 54(3):277-85. PubMed ID: 1982548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
    Sekiguchi H; Hamada K; Taga F; Nishino K
    Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of IT-066, a new histamine H2-receptor antagonist, on gastric acid secretion and experimental gastric ulcers in rats and dogs].
    Okabe S; Nishida T; Igata H; Takagi K
    Nihon Yakurigaku Zasshi; 1990 May; 95(5):247-56. PubMed ID: 1972370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JB-9322, a new selective histamine H2-receptor antagonist with potent gastric mucosal protective properties.
    Palacios B; Montero MJ; Sevilla MA; Román LS
    Br J Pharmacol; 1995 May; 115(1):57-66. PubMed ID: 7647984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
    Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
    Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
    Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
    Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
    Sekiguchi H; Hamada K; Kobayashi F; Taga F; Uchida H
    Arzneimittelforschung; 1993 Feb; 43(2):129-33. PubMed ID: 8096132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological and therapeutic properties of lafutidine (stogar and protecadin), a novel histamine H2 receptor antagonist with gastroprotective activity].
    Tanaka M; Banba M; Joko A; Moriyama Y
    Nihon Yakurigaku Zasshi; 2001 Jun; 117(6):377-86. PubMed ID: 11436515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
    Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
    Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
    Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M
    Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
    Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
    Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric antisecretory and antiulcer activity of oxytocin in rats and guinea pigs.
    Asad M; Shewade DG; Koumaravelou K; Abraham BK; Vasu S; Ramaswamy S
    Life Sci; 2001 Nov; 70(1):17-24. PubMed ID: 11764003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
    Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
    Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of KW-5805, a new antiulcer agent, on experimental gastric and duodenal ulcers, gastric mucosal lesions by necrotizing agents and gastric acid secretion.
    Kosaka N; Tanaka H; Tomaru A; Ishii A; Shuto K
    Jpn J Pharmacol; 1994 Aug; 65(4):305-12. PubMed ID: 7990267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.